Stocktoria
EDAP TMS SA FOCL
Nasdaq · XNAS · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 1997-08-01
EDAP TMS SA financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $70.5M | $69.4M | $60.4M | $55.1M | $44.1M |
| Gross profit | $30.0M | $28.7M | $24.4M | $24.2M | $18.4M |
| R&D expense | $9.7M | $8.4M | $7.0M | $4.9M | $3.4M |
| Operating income | -$24.7M | -$22.2M | -$19.8M | -$4.3M | -$1.6M |
| Interest expense | — | — | $232,000 | $168,000 | $52,000 |
| Income tax | $438,000 | $313,000 | $644,000 | $837,000 | $193,000 |
| Net income | -$29.2M | -$20.6M | -$21.2M | -$2.9M | $699,890 |
| EPS (diluted) | $-0.78 | $-0.55 | $-0.57 | $-0.09 | $0.02 |
| Operating cash flow | -$16.4M | -$14.7M | -$14.7M | -$3.0M | $4.4M |
| Cash & equivalents | $20.5M | $31.0M | $43.5M | $63.1M | $47.2M |
| Inventory | $12.8M | $19.2M | $15.1M | $11.8M | $7.5M |
| Total assets | $79.0M | $89.4M | $91.5M | $101.1M | $77.2M |
| Total liabilities | $59.6M | $46.9M | $34.6M | $29.5M | $27.2M |
| Shareholders' equity | $19.4M | $42.5M | $62.9M | $71.6M | $50.1M |
Source: SEC EDGAR filings · CIK 0001041934 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.